EXCLUSIVE OFFER
15% OFF
when you order 10 or more vials
Free shipping included 🚚
Discount applied automatically at checkout
TIRZMolecular Weight4,813.45 Da
Purity≥99%
CategoryGLP-1 Agonists
Status
In Stock
TESTED
COLD-CHAIN
CANADA
GLP-1 AGONISTS
Tirzepatide
A dual GIP/GLP-1 receptor agonist representing next-generation incretin research. Superior efficacy profile in metabolic studies.
SELECT SIZE
PRICE PER VIALCA$45.00CAD
10+ VIALSCA$382.5015% BULK DISCOUNT
5mg per vial · mg/vial
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. This 39-amino acid synthetic peptide features a C20 fatty di-acid moiety enabling weekly dosing. SURPASS and SURMOUNT clinical trial programs demonstrated unprecedented A1C reduction and weight loss outcomes, establishing a new benchmark in metabolic research.
Key Research Applications
Dual GIP/GLP-1 action
Superior A1C reduction
Weight management research
Weekly dosing protocol
Next-gen incretin research
Research Dosage Calculator
4 weeks
1 wk24 wks
CALCULATED REQUIREMENTS
DOSE PER INJECTION0.5 mg
TOTAL INJECTIONS4
TOTAL mg NEEDED2 mg
VIALS REQUIRED1 vial
RECONSTITUTION GUIDE (per 5mg vial + 1mL BAC water)Draw 0.100 mL per injection
ESTIMATED COST~$NaN USD
For research use only. Dosage calculations are estimates based on published research protocols. Consult primary literature for your specific research application.